Re-HEDP : pharmacokinetic characterization, clinical and dosimetric evaluation in osseous metastatic patients with two levels of radiopharmaceutical dose

BACKGROUND: A study for pain relief therapy with (188)Re-HEDP was done in patients with bone metastases secondary to breast and prostate cancer. MATERIALS AND METHODS: Patients received 1.3 or 2.2 GBq, in single or multiple doses. Platelets, white and red cells were evaluated during 11 weeks. Pharma...

Descripción completa

Detalles Bibliográficos
Autores principales: Savio, Eduardo, Gaudiano, Javier, Robles, Ana M, Balter, Henia, Paolino, Andrea, López, Andrea, Hermida, Juan C, De Marco, Eugenia, Martinez, Graciela, Osinaga, Eduardo, Knapp, Furn F
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2001
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC60657/
https://www.ncbi.nlm.nih.gov/pubmed/11734069
http://dx.doi.org/10.1186/1471-2385-1-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC60657/
https://www.ncbi.nlm.nih.gov/pubmed/11734069
http://dx.doi.org/10.1186/1471-2385-1-2

Ejemplares similares